Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Elafibranor bulk supplier for pharma manufacturers

Elafibranor 80 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 80 mg

Reference Brands: Iqirvo (USA/EU)

Category: Gastrointestinal Drugs

Elafibranor is an oral dual PPAR-α and PPAR-δ agonist used for the treatment of primary biliary cholangitis. It helps improve liver function, reduce bile acid accumulation, and lower inflammation, supporting better long-term liver health.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Elafibranor — third party manufacturing & bulk supply

Elafibranor 80 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Elafibranor listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Elafibranor →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Elafibranor is used for treating primary biliary cholangitis in adults who do not respond adequately to ursodeoxycholic acid or cannot tolerate it. It works as a dual PPAR-α/δ agonist that helps reduce liver inflammation and improve bile flow.

Elafibranor is made from the active ingredient elafibranor, a synthetic peroxisome proliferator-activated receptor (PPAR) agonist that targets metabolic and inflammatory pathways involved in cholestatic liver disease.

The trade name is Iqirvo.

Iqirvo is manufactured and marketed by Ipsen in collaboration with Genfit, the company that originally developed the drug.

The generic name is elafibranor.

The brand name is Iqirvo.

Elafibranor is manufactured in Europe and the United States through Ipsen’s and Genfit’s regulated pharmaceutical production facilities.

Related Products

Bismuth Subsalicylate

Strength:
262 mg, 525 mg

Form: Oral suspension / Tablet

Reference Brands: Pepto-Bismol (USA/LATAM),

View Details
Plecanatide

Strength:
3 mg

Form: Tablets

Reference Brands: Trulance (USA)

View Details
Naldemedine

Strength:
0.2 mg

Form: Tablets

Reference Brands: Symproic (USA/EU)

View Details
Resmetirom

Strength:
80 mg ,100 mg

Form: Tablets

Reference Brands: Rezdiffra (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.